{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:44:14Z","timestamp":1774449854306,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T00:00:00Z","timestamp":1678579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T00:00:00Z","timestamp":1678579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81800808"],"award-info":[{"award-number":["81800808"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Innovation capability support plan of Shaanxi Province","award":["2018KJXX-051"],"award-info":[{"award-number":["2018KJXX-051"]}]},{"name":"Military medical transformation project of Tangdu hospital","award":["2021JSZH-007"],"award-info":[{"award-number":["2021JSZH-007"]}]},{"name":"Military prospective research project of Tangdu hospital","award":["2020QZDY004"],"award-info":[{"award-number":["2020QZDY004"]}]},{"name":"2019 seedling talent project of Tangdu hospital"},{"name":"Discipline innovation development plan of Tangdu hospital","award":["2021ZTXM-011"],"award-info":[{"award-number":["2021ZTXM-011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Orbital lymphoma is one of the most common adult orbital malignancies, accounting for approximately 10% of all orbital tumors. This study aimed to analyze the effects of surgical resection and orbital iodine-125 brachytherapy implantation for orbital lymphoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Patients and methods<\/jats:title>\n                <jats:p>This was a retrospective study. Clinical data of 10 patients were collected from October 2016 to November 2018 and followed up to March 2022. Patients underwent the primary surgery for maximal safe removal of the tumor. After a pathologic diagnosis of a primary orbital lymphoma was established, iodine-125 seed tubes were designed based on the tumor size and invasion range, and direct vision was placed into the nasolacrimal canal or\/and under the orbital periosteum around the resection cavity during the secondary surgery. Then, follow-up data, including the general situation, ocular condition, and tumor recurrence, were recorded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 10 patients, the pathologic diagnoses included extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (6 cases), small lymphocytic lymphoma (1 case), mantle cell lymphoma (2 cases), and diffuse large B-cell lymphoma (1 case). The number of seeds implanted ranged from 16 to 40. The follow-up period ranged between 40 and 65\u00a0months. All patients in this study were alive and well had tumors that were completely controlled. No tumor recurrences or metastases occurred. Three patients had dry eye syndrome and two patients had abnormal facial sensation. No patient had radiodermatitis involving the skin around the eye, and no patient had radiation-related ophthalmopathy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Based on preliminary observations, iodine-125 brachytherapy implantation appeared to be a reasonable alternative to external irradiation for orbital lymphoma.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10792-022-02594-x","type":"journal-article","created":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T07:02:31Z","timestamp":1678604551000},"page":"1945-1955","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Surgical resection and orbital iodine-125 brachytherapy for orbital malignancy: a novel treatment for orbital lymphoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Nan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaona","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenjun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qilin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-452X","authenticated-orcid":false,"given":"Yangjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,12]]},"reference":[{"issue":"1","key":"2594_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1755-3768.2008.01478.x","volume":"87","author":"LD Sjo","year":"2009","unstructured":"Sjo LD (2009) Ophthalmic lymphoma: epidemiology and pathogenesis. Acta Ophthalmol 87(1):1\u201320","journal-title":"Acta Ophthalmol"},{"key":"2594_CR2","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.5858\/133.8.1262","volume":"133","author":"SE Coupland","year":"2009","unstructured":"Coupland SE, White VA, Rootman J, Damato B, Finger PT (2009) A TNM-based clinical staging system of ocular adnexal lymphomas. Arch Pathol Lab Med 133:1262\u20131267","journal-title":"Arch Pathol Lab Med"},{"key":"2594_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1477-7819-11-73","volume":"11","author":"AM Eckardt","year":"2013","unstructured":"Eckardt AM, Lemound J, Rana M, Gellrich NC (2013) Orbital lymphoma: diagnostic approach and treatment outcome. World J Surg Oncol 11:73","journal-title":"World J Surg Oncol"},{"key":"2594_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1097\/ICU.0b013e3282be8fbb","volume":"18","author":"FP Bernardini","year":"2007","unstructured":"Bernardini FP, Bazzan M (2007) Lymphoproliferative disease of the orbit. Curr Opin Ophthalmol 18:398\u2013401","journal-title":"Curr Opin Ophthalmol"},{"key":"2594_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0161-6420(01)00932-0","volume":"109","author":"H Demirci","year":"2002","unstructured":"Demirci H, Shields CL, Shields JA, Honavar SG, Mercado GJ, Tovilla JC (2002) Orbital tumors in the older adult population. Ophthalmology 109:243\u2013248","journal-title":"Ophthalmology"},{"key":"2594_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1076\/orbi.20.2.119.2633","volume":"20","author":"F Tranfa","year":"2001","unstructured":"Tranfa F, Di Matteo G, Strianese D, Forte R, Bonavolonta G (2001) Primary orbital lymphoma. Orbit 20:119\u2013124","journal-title":"Orbit"},{"key":"2594_CR7","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/01.pas.0000213350.49767.46","volume":"31","author":"JA Ferry","year":"2007","unstructured":"Ferry JA, Fung CY, Zukerberg L, Lucarelli MJ, Hasserjian RP, Preffer FI, Harris NL (2007) Lymphoma of the ocular adnexa: a study of 353 cases. Am J Surg Pathol 31:170\u2013184","journal-title":"Am J Surg Pathol"},{"key":"2594_CR8","first-page":"58","volume-title":"Revised","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe EL, Pileri SA, Stein H et al (2017) WHO classification of tumours of haematopoietic and lymphoid tissues. In: Swerdlow SH (ed) Revised, 4th edn. IARC, Lyon, p 58","edition":"4"},{"key":"2594_CR9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1182\/blood-2006-02-005017","volume":"108","author":"D Decaudin","year":"2006","unstructured":"Decaudin D, de Cremoux P, Vincent-Salomon A, Dendale R, Rouic LL (2006) Ocular adnexal lymphoma: a review of clinicopathologic features and treatment options. Blood 108:1451\u20131460","journal-title":"Blood"},{"key":"2594_CR10","doi-asserted-by":"publisher","first-page":"e659","DOI":"10.1016\/j.ijrobp.2011.03.050","volume":"81","author":"JS Goda","year":"2011","unstructured":"Goda JS, Le LW, Lapperriere NJ, Millar BA, Payne D, Gospodarowicz MK et al (2011) Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity. Int J Radiat Oncol Biol Phys 81:e659-666","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2594_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11060-008-9686-2","volume":"91","author":"K Huang","year":"2009","unstructured":"Huang K, Sneed PK, Kunwar S, Kragten A, Larson DA, Berger MS et al (2009) Surgical resection and permanent iodine-125 brachytherapy for brain metastases. J Neurooncol 91:83\u201393","journal-title":"J Neurooncol"},{"key":"2594_CR12","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/foc.2007.22.3.4","volume":"22","author":"E Dagnew","year":"2007","unstructured":"Dagnew E, Kanski J, McDermott MW, Sneed PK, McPherson C, Breneman JC et al (2007) Management of newly diagnosed single brain metastasis using resection and permanent iodine-125 seeds without initial whole-brain radiotherapy: a two institution experience. Neurosurg Focus 22:E3","journal-title":"Neurosurg Focus"},{"key":"2594_CR13","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1227\/00006123-198909000-00019","volume":"25","author":"PP Kumar","year":"1989","unstructured":"Kumar PP, Good RR, Patil AA, Leibrock LG (1989) Permanent high-activity iodine-125 in the management of petroclival meningiomas: case reports. Neurosurgery 25:436\u2013441","journal-title":"Neurosurgery"},{"key":"2594_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000069502","volume":"79","author":"PC Obasi","year":"2002","unstructured":"Obasi PC, Barnett GH, Suh JH (2002) Brachytherapy for intracranial meningioma using a permanently implanted iodine-125 seed. Stereotact Funct Neurosurg 79:33\u201343","journal-title":"Stereotact Funct Neurosurg"},{"key":"2594_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1227\/00006123-198706000-00020","volume":"20","author":"PH Gutin","year":"1987","unstructured":"Gutin PH, Leibel SA, Hosobuchi Y, Crumley RL, Edwards MS, Wilson CB et al (1987) Brachytherapy of recurrent tumors of the skull base and spine with iodine-125 sources. Neurosurgery 20:938\u2013945","journal-title":"Neurosurgery"},{"key":"2594_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1227\/01.NEU.0000097199.26412.2A","volume":"54","author":"ML Ware","year":"2004","unstructured":"Ware ML, Larson DA, Sneed PK, Wara WW, McDermott MW (2004) Surgical resection and permanent brachytherapy for recurrent atypical and malignant meningioma. Neurosurgery 54:55\u201363","journal-title":"Neurosurgery"},{"key":"2594_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1118\/1.595423","volume":"10","author":"H Kubo","year":"1983","unstructured":"Kubo H (1983) Determination of the half-life of I-125 encapsulated clinical seeds using a Si (Li) detector. Med Phys 10:889\u2013891","journal-title":"Med Phys"},{"key":"2594_CR18","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/S0161-6420(01)00797-7","volume":"108","author":"CL Shields","year":"2001","unstructured":"Shields CL, Shields JA, Cater J, Othmane I, Singh AD, Micaily B (2001) Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology 108:2116\u20132121","journal-title":"Ophthalmology"},{"key":"2594_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/eye.2012.241","volume":"27","author":"C Stannard","year":"2013","unstructured":"Stannard C, Sauerwein W, Maree G, Lecuona K (2013) Radiotherapy for ocular tumours. Eye (Lond) 27:119\u2013127","journal-title":"Eye (Lond)"},{"key":"2594_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/COC.0b013e31816d1c94","volume":"31","author":"SC Oliver","year":"2008","unstructured":"Oliver SC, Young TA, Kobe LH, Leu MY, Lee SP, Chun MW et al (2008) Assessment of central vision and macular structure in patients undergoing iodine-125 brachytherapy for ciliochoroidal melanoma. Am J Clin Oncol 31:488\u2013492","journal-title":"Am J Clin Oncol"},{"key":"2594_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/01.IOP.0000056020.66654.33","volume":"19","author":"JA Shields","year":"2003","unstructured":"Shields JA, Shields CL, Freire JE, Brady LW, Komarnicky L (2003) Plaque radiotherapy for selected orbital malignancies: preliminary observations: the 2002 Montgomery Lecture, part 2. Ophthalmic Plast Reconstr Surg 19:91\u201395","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2594_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5114\/jcb.2017.70957","volume":"9","author":"S Laskar","year":"2017","unstructured":"Laskar S, Pilar A, Khanna N, Ghadi Y (2017) Interstitial brachytherapy for orbital soft tissue sarcoma: an innovative technique. J Contemp Brachytherapy 9:466\u2013471","journal-title":"J Contemp Brachytherapy"},{"issue":"4","key":"2594_CR23","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41433-020-1098-3","volume":"35","author":"P Wang","year":"2021","unstructured":"Wang P, Ma N, Zhang SB, Ning XN, Guo CJ, Zhang Q, Cheng QL, Li YJ (2021) Iodine-125 interstitial brachytherapy for malignant lacrimal sac tumours: an innovative technique. Eye (Lond) 35(4):1240\u20131247","journal-title":"Eye (Lond)"},{"key":"2594_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.survophthal.2018.08.002","volume":"64","author":"TG Olsen","year":"2019","unstructured":"Olsen TG, Heegaard S (2019) Orbital lymphoma. Surv Ophthalmol 64:45\u201366","journal-title":"Surv Ophthalmol"},{"key":"2594_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/COC.0000000000000229","volume":"41","author":"SM Kharod","year":"2018","unstructured":"Kharod SM, Herman MP, Morris CG, Lightsey J, Mendenhall WM, Mendenhall NP (2018) Radiotherapy in the management of orbital lymphoma: a single institution\u2019s experience over 4 decades. Am J Clin Oncol 41:100\u2013106","journal-title":"Am J Clin Oncol"},{"key":"2594_CR26","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1227\/NEU.0000000000001262","volume":"80","author":"TM Stephen","year":"2017","unstructured":"Stephen TM, Darryl L, David RR, Penny KS, Shannon EF, Michael WM (2017) Surgical resection and interstitial iodine-125 brachytherapy for high-grade meningiomas: a 25-year series. Neurosurgery 80:409\u2013416","journal-title":"Neurosurgery"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02594-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-022-02594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T07:23:14Z","timestamp":1684740194000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-022-02594-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,12]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1007\/s10792-022-02594-x","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,12]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author reports no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}}]}}